Buscar
-
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Dual Orexin Receptor Antagonists and Suicide Risk: Findings From the WHO Spontaneous Reporting Database
(Journal of Clinical Psychiatry. vol. 84, n° 6, 2023-09-27)Article de revue -
Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older Patients with Metastatic Colorectal Cancer
(Targeted Oncology. vol. 18, n° 5, pp. 717-726, 2023-09-01)Article de revue -
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective
(Therapies, 2023-03-07)Article de revue -
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
(Therapies, 2023-03-11)Article de revue -
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study
(British Journal of Haematology. vol. 203, n° 2, pp. 311-318, 2023-10-01)Article de revue -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
(Drug Safety. vol. 46, n° 9, pp. 857-866, 2023-09-01)Article de revueLibre acceso -
Safety of antituberculosis agents used for multidrug-resistant tuberculosis among patients attending the Jamot Hospital of Yaounde, Cameroon
(International Journal of Mycobacteriology. vol. 12, n° 2, pp. 168-174, 2023-06-15)Article de revueLibre acceso -
Interpretation of Pharmacovigilance Disproportionality Analyses
(Clinical Pharmacology and Therapeutics, 2023-05-30)Article de revue -
Adverse Drug Reaction-Related to Drug Shortage: A Retrospective Study on the French National Pharmacovigilance Database
(British Journal of Clinical Pharmacology. vol. 89, n° 3, pp. 1080-1088, 2023-03)Article de revueLibre acceso